12 results on '"Carrillo, Elena"'
Search Results
2. Pandemic-Era Administrative Decision-Making Informed by Patron and Employee Feedback.
- Author
-
Scoulas, Jung Mi, Carrillo, Elena, and Naru, Linda
- Subjects
- *
DECISION making , *COVID-19 pandemic , *USER experience , *EMPLOYEE attitude surveys , *LIBRARY users , *PATRONAGE , *LIBRARY personnel - Abstract
This article follows up on two previously published studies regarding the incorporation of student feedback amid the COVID-19 pandemic. It builds on the model of embracing user experience, focusing on how library employees and patrons felt about the health safety protocols in place during Fall 2021. Analyzing both surveys from employees and patrons, the findings indicated that both groups felt safe in the library. This article recommends that when library decision-makers are in doubt about policies and practices, they should consult with the groups directly affected, and demonstrates the importance of ensuring stakeholders feel heard and can contribute to decision-making. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Assessing User Experience: Incorporating Student Voice in Libraries' Pandemic Response.
- Author
-
Scoulas, Jung Mi, Carrillo, Elena, and Naru, Linda
- Subjects
- *
USER experience , *ACADEMIC libraries , *PANDEMICS , *COVID-19 , *LIBRARY users , *RESERVATION systems - Abstract
This article demonstrates how a public research university library responded to user needs following radical service changes during Fall 2020 and assesses whether the library met challenges resulting from COVID-19. The library reduced hours and occupancy and implemented a reservation system and new health safety guidelines with the goal of a safe environment. During Fall 2020, 540 survey respondents reported feeling their health was not at risk, suggesting the goal was accomplished. Additionally, users provided feedback about the altered landscape. This article will benefit administrators and user experience librarians who need to balance user preferences and administrative reality. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
- Author
-
Berkhout, Ben and Herrera-Carrillo, Elena
- Subjects
- *
SARS-CoV-2 Omicron variant , *SARS-CoV-2 , *CORONAVIRUSES , *COVID-19 - Abstract
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and harbors many mutations in the spike protein, but the origin of this virus variant remains unclear. We address the role of unusual virus evolution mechanisms such as hypermutation, out-of-frame reading, and recombination. Rather, regular Darwinian evolution, that is, the repeated selection of beneficial spike mutations, seems to have led to the appearance of the grossly altered spike protein of the Omicron variant. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. AAV vectors displaying bispecific DARPins enable dual-control targeted gene delivery.
- Author
-
Theuerkauf, Samuel A., Herrera-Carrillo, Elena, John, Fabian, Zinser, Luca J., Molina, Mariano A., Riechert, Vanessa, Thalheimer, Frederic B., Börner, Kathleen, Grimm, Dirk, Chlanda, Petr, Berkhout, Ben, and Buchholz, Christian J.
- Subjects
- *
BISPECIFIC antibodies , *GENETIC vectors , *BIOLOGICAL products , *VIRAL tropism , *GENE therapy , *LOGIC circuits , *GENES - Abstract
Precise delivery of genes to therapy-relevant cells is crucial for in vivo gene therapy. Receptor-targeting as prime strategy for this purpose is limited to cell types defined by a single cell-surface marker. Many target cells are characterized by combinations of more than one marker, such as the HIV reservoir cells. Here, we explored the tropism of adeno-associated viral vectors (AAV2) displaying designed ankyrin repeat proteins (DARPins) mono- and bispecific for CD4 and CD32a. Cryo-electron tomography revealed an unaltered capsid structure in the presence of DARPins. Surprisingly, bispecific AAVs transduced CD4/CD32a double-positive cells at much higher efficiencies than single-positive cells, even if present in low amounts in cell mixtures or human blood. This preference was confirmed when vector particles were systemically administered into mice. Cell trafficking studies revealed an increased cell entry rate for bispecific over monospecific AAVs. When equipped with an HIV genome-targeting CRISPR/Cas cassette, the vectors prevented HIV replication in T cell cultures. The data provide proof-of-concept for high-precision gene delivery through tandem-binding regions on AAV. Reminiscent of biological products following Boolean logic AND gating, the data suggest a new option for receptor-targeted vectors to improve the specificity and safety of in vivo gene therapy. [Display omitted] • Preferred transduction of cells expressing two surface markers by bispecific AAVs. • Incorporation of two DARPins without detectable structural changes in the capsid. • Increased uptake rates of bispecific versus monospecific AAVs. • New options for precise in vivo gene delivery to therapy-relevant cells. • Targeting of the HIV reservoir as potential application. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. In-house ELISA protocols for capsid p24 detection of diverse HIV isolates.
- Author
-
Molina, Mariano A., Vink, Monique, Berkhout, Ben, and Herrera-Carrillo, Elena
- Subjects
- *
AIDS serodiagnosis , *HIV , *DIAGNOSIS of HIV infections , *ENZYME-linked immunosorbent assay , *ANTIBODY titer - Abstract
Background: The capsid p24 (CA-p24) antigen is a component of the viral capsid of human immunodeficiency virus (HIV) that has been commonly used for clinical diagnosis and monitoring of HIV infections in Enzyme-linked Immunosorbent Assays (ELISAs). Commercial CA-p24 ELISAs are widely used in research settings, but these kits are costly and have limited breadth for detecting diverse HIV isolates. Methods: Commercial CA-p24 antibodies were used as capture and detection antibodies. Specific CA-p24 ELISAs were established with these antibodies and tested for the detection of HIV-1 isolates with the aim of developing in-house protocols to recognize HIV-1 infections in vitro for research purposes. Results: Here we present four protocols for in-house ELISAs to detect HIV CA-p24 using commercial antibodies. The assays were able to detect the CA-p24 antigen of different HIV-1 isolates tested. Comparison between the protocols showed that these in-house ELISAs exhibit high specificity, sensitivity, and reproducibility for CA-p24 quantitation but their reactivity varied per HIV-1 isolate and subtype. Conclusions: These optimized ELISA protocols represent valuable tools to investigate HIV-1 infections in research facilities at a lower price than commercial CA-p24 kits. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. FcγRIIA-specific DARPins as novel tools in blood cell analysis and platelet aggregation.
- Author
-
Riechert, Vanessa, Hein, Sascha, Visser, Mayken, Zimmermann, Mathias, Wesche, Jan, Adams, Philipp A., Theuerkauf, Samuel A., Jamali, Arezoo, Wangorsch, Andrea, Reuter, Andreas, Pasternak, Alexander O., Hartmann, Jessica, Greinacher, Andreas, Herrera-Carrillo, Elena, Berkhout, Ben, Cichutek, Klaus, and Buchholz, Christian J.
- Subjects
- *
CELL analysis , *BLOOD cells , *CELL populations , *BLOOD testing , *T cells , *BLOOD platelet aggregation - Abstract
Fc receptors are involved in a variety of physiologically and disease-relevant responses. Among them, FcγRIIA (CD32a) is known for its activating functions in pathogen recognition and platelet biology, and, as potential marker of T lymphocytes latently infected with HIV-1. The latter has not been without controversy due to technical challenges complicated by T-B cell conjugates and trogocytosis as well as a lack of antibodies distinguishing between the closely related isoforms of FcγRII. To generate high-affinity binders specific for FcγRIIA, libraries of designed ankyrin repeat proteins (DARPins) were screened for binding to its extracellular domains by ribosomal display. Counterselection against FcγRIIB eliminated binders crossreacting with both isoforms. The identified DARPins bound FcγRIIA with no detectable binding for FcγRIIB. Their affinities for FcγRIIA were in the low nanomolar range and could be enhanced by cleavage of the His-tag and dimerization. Interestingly, complex formation between DARPin and FcγRIIA followed a two-state reaction model, and discrimination from FcγRIIB was based on a single amino acid residue. In flow cytometry, DARPin F11 detected FcγRIIA+ cells even when they made up less than 1% of the cell population. Image stream analysis of primary human blood cells confirmed that F11 caused dim but reliable cell surface staining of a small subpopulation of T lymphocytes. When incubated with platelets, F11 inhibited their aggregation equally efficient as antibodies unable to discriminate between both FcγRII isoforms. The selected DARPins are unique novel tools for platelet aggregation studies as well as the role of FcγRIIA for the latent HIV-1 reservoir. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2.
- Author
-
Hussein, Mouraya, Andrade dos Ramos, Zaria, Vink, Monique A., Kroon, Pascal, Yu, Zhenghao, Enjuanes, Luis, Zuñiga, Sonia, Berkhout, Ben, and Herrera-Carrillo, Elena
- Subjects
- *
SARS-CoV-2 , *GENOME editing , *ANTIVIRAL agents , *RNA editing , *VIRAL genomes , *COVID-19 pandemic , *CRISPRS , *CORONAVIRUSES - Abstract
The current SARS-CoV-2 pandemic forms a major global health burden. Although protective vaccines are available, concerns remain as new virus variants continue to appear. CRISPR-based gene-editing approaches offer an attractive therapeutic strategy as the CRISPR-RNA (crRNA) can be adjusted rapidly to accommodate a new viral genome sequence. This study aimed at using the RNA-targeting CRISPR-Cas13d system to attack highly conserved sequences in the viral RNA genome, thereby preparing for future zoonotic outbreaks of other coronaviruses. We designed 29 crRNAs targeting highly conserved sequences along the complete SARS-CoV-2 genome. Several crRNAs demonstrated efficient silencing of a reporter with the matching viral target sequence and efficient inhibition of a SARS-CoV-2 replicon. The crRNAs that suppress SARS-CoV-2 were also able to suppress SARS-CoV, thus demonstrating the breadth of this antiviral strategy. Strikingly, we observed that only crRNAs directed against the plus-genomic RNA demonstrated antiviral activity in the replicon assay, in contrast to those that bind the minus-genomic RNA, the replication intermediate. These results point to a major difference in the vulnerability and biology of the +RNA versus −RNA strands of the SARS-CoV-2 genome and provide important insights for the design of RNA-targeting antivirals. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. A CRISPR-Cas Cure for HIV/AIDS.
- Author
-
Hussein, Mouraya, Molina, Mariano A., Berkhout, Ben, and Herrera-Carrillo, Elena
- Subjects
- *
CRISPRS , *AIDS , *HIV , *HIV infections , *GENOME editing , *VIRAL genes - Abstract
Human immunodeficiency virus (HIV) infections and HIV-induced acquired immunodeficiency syndrome (AIDS) continue to represent a global health burden. There is currently no effective vaccine, nor any cure, for HIV infections; existing antiretroviral therapy can suppress viral replication, but only as long as antiviral drugs are taken. HIV infects cells of the host immune system, and it can establish a long-lived viral reservoir, which can be targeted and edited through gene therapy. Gene editing platforms based on the clustered regularly interspaced palindromic repeat-Cas system (CRISPR-Cas) have been recognized as promising tools in the development of gene therapies for HIV infections. In this review, we evaluate the current landscape of CRISPR-Cas-based therapies against HIV, with an emphasis on the infection biology of the virus as well as the activity of host restriction factors. We discuss the potential of a combined CRISPR-Cas approach that targets host and viral genes to activate antiviral host factors and inhibit viral replication simultaneously. Lastly, we focus on the challenges and potential solutions of CRISPR-Cas gene editing approaches in achieving an HIV cure. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Prevalence of post-intensive care syndrome in mechanically ventilated patients with COVID-19.
- Author
-
Nanwani-Nanwani, Kapil, López-Pérez, Lorenzo, Giménez-Esparza, Carola, Ruiz-Barranco, Inés, Carrillo, Elena, Arellano, María Soledad, Díaz-Díaz, Domingo, Hurtado, Beatriz, García-Muñoz, Andoni, Relucio, María Ángeles, Quintana-Díaz, Manuel, Úrbez, María Rosario, Saravia, Andrés, Bonan, María Victoria, García-Río, Francisco, Testillano, María Luisa, Villar, Jesús, García de Lorenzo, Abelardo, and Añón, José Manuel
- Subjects
- *
COVID-19 , *SARS-CoV-2 , *SICK leave , *MENTAL illness , *MONTREAL Cognitive Assessment - Abstract
Coronavirus disease 19 (COVID-19) patients usually require long periods of mechanical ventilation and sedation, which added to steroid therapy, favours a predisposition to the development of delirium and subsequent mental health disorders, as well as physical and respiratory sequelae. The aim of this study was to determine the prevalence of post-intensive care syndrome (PICS) at 3 months after hospital discharge, in a cohort of mechanically ventilated patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An ambispective, observational study was conducted in three hospitals with intensive care unit (ICU) follow-up clinics. We studied adults who survived a critical illness due to SARS-CoV-2 infection requiring invasive mechanical ventilation. A physical (muscle strength and pulmonary function), functional [12-Item Short Form Health Survey (SF-12), and Barthel score], psychological [hospital anxiety and depression (HADS) and posttraumatic stress disorder symptom severity scales], and cognitive [Montreal cognitive assessment (MoCA) test] assessment were performed. A total of 186 patients were evaluated at 88 days (IQR 68–121) after hospital discharge. Mean age was 59 ± 12 years old, 126 (68%) patients were men, and median length of mechanical ventilation was 14 days (IQR 8–31). About 3 out of 4 patients (n = 139, 75%) met PICS criteria. Symptoms of cognitive and psychiatric disorders were found in 59 (32%) and 58 (31%) patients, respectively. Ninety-one (49%) patients had muscle weakness. Pulmonary function tests in patients with no respiratory comorbidities showed a normal pattern in 93 (50%) patients, and a restrictive disorder in 62 (33%) patients. Also, 69 patients (37%) were on sick leave, while 32 (17%) had resumed work at the time of assessment. In conclusion, survivors of critical illness due to SARS-CoV-2 infection requiring mechanical ventilation have a high prevalence of PICS. Physical domain is the most frequently damaged, followed by cognitive and psychiatric disorders. ICU follow-up clinics enable the assistance of this vulnerable population. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures.
- Author
-
Fan, Minghui, Bao, Yuanling, Berkhout, Ben, and Herrera-Carrillo, Elena
- Subjects
- *
T cells , *CELL culture , *HIV , *HIV infections , *VIRAL shedding , *VIRUS inactivation , *ENDONUCLEASES - Abstract
The novel endonuclease Cas12b was engineered for targeted genome editing in mammalian cells and is a promising tool for certain applications because of its small size, high sequence specificity and ability to generate relatively large deletions. We previously reported inhibition of the human immunodeficiency virus (HIV) in cell culture infections upon attack of the integrated viral DNA genome by spCas9 and Cas12a. We now tested the ability of the Cas12b endonuclease to suppress a spreading HIV infection in cell culture with anti-HIV gRNAs. Virus inhibition was tested in long-term HIV replication studies, which allowed us to test for viral escape and the potential for reaching a CURE of the infected T cells. We demonstrate that Cas12b can achieve complete HIV inactivation with only a single gRNA, a result for which Cas9 required two gRNAs. When the Cas12b system is programmed with two antiviral gRNAs, the overall anti-HIV potency is improved and more grossly mutated HIV proviruses are generated as a result of multiple cut-repair actions. Such "hypermutated" HIV proviruses are more likely to be defective due to mutation of multiple essential parts of the HIV genome. We report that the mutational profiles of the Cas9, Cas12a and Cas12b endonucleases differ significantly, which may have an impact on the level of virus inactivation. These combined results make Cas12b the preferred editing system for HIV-inactivation. These results provide in vitro "proof of concept' for CRISPR-Cas12b mediated HIV-1 inactivation. [Display omitted] • CRISPR-Cas12b-based strategies that result in inactivation of integrated HIV genomes hold promise as a potential cure for HIV. • Cas12b can achieve full HIV inactivation with only a single gRNA. • Combination of two antiviral gRNAs led to improved anti-HIV potency and more grossly mutated HIV proviruses. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack.
- Author
-
Hussein, Mouraya, Andrade dos Ramos, Zaria, Berkhout, Ben, and Herrera-Carrillo, Elena
- Subjects
- *
SARS-CoV-2 Omicron variant , *COVID-19 pandemic , *MOLECULAR biology , *CRISPRS , *VACCINE development - Abstract
The SARS-CoV-2 pandemic has urged the development of protective vaccines and the search for specific antiviral drugs. The modern molecular biology tools provides alternative methods, such as CRISPR-Cas and RNA interference, that can be adapted as antiviral approaches, and contribute to this search. The unique CRISPR-Cas13d system, with the small crRNA guide molecule, mediates a sequence-specific attack on RNA, and can be developed as an anti-coronavirus strategy. We analyzed the SARS-CoV-2 genome to localize the hypothetically best crRNA-annealing sites of 23 nucleotides based on our extensive expertise with sequence-specific antiviral strategies. We considered target sites of which the sequence is well-conserved among SARS-CoV-2 isolates. As we should prepare for a potential future outbreak of related viruses, we screened for targets that are conserved between SARS-CoV-2 and SARS-CoV. To further broaden the search, we screened for targets that are conserved between SARS-CoV-2 and the more distantly related MERS-CoV, as well as the four other human coronaviruses (OC43, 229E, NL63, HKU1). Finally, we performed a search for pan-corona target sequences that are conserved among all these coronaviruses, including the new Omicron variant, that are able to replicate in humans. This survey may contribute to the design of effective, safe, and escape-proof antiviral strategies to prepare for future pandemics. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.